Live Chat

Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Info

Spread

0.33

Spread (%)

0.6221 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

106762878976

Shares Outstanding

2027399936

Earnings Date (Next)

2001-08-07

Div Yield

2024-11-01

Ex-Dividend Date

2024-10-04

Forward annual dividend rate

2.4

Forward annual dividend yield

0.0457

EPS

-3.25

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
view_all_instruments

Latest news

Stay updated with the latest financial news from around the world.

Wednesday, 30 October 2024

Robinhood stock price climbs 4% after debuting presidential election betting

Wednesday, 30 October 2024

Warren Buffett Sold $80 Billion of Apple Stock (AAPL)

Euro stock market

Wednesday, 30 October 2024

Europe’s Budget Worries, US Tech Earnings, and China’s Growth Signals

Wednesday, 30 October 2024

Gold price hits record high on US election uncertainty, geopolitical risks

Wednesday, 30 October 2024

MSFT share news: Microsoft AI Business Set To Hit $10B Revenue In Q2

UK Budget

Wednesday, 30 October 2024

UK Budget: Investor Reactions, FTSE Movements, and Fiscal Projections

Tuesday, 29 October 2024

AI propelled the stock prices of tech companies: MSFT, AMZN, NVDA, and GOOG

Tuesday, 29 October 2024

Alphabet shares rise on strong Q3 Earnings, revenue of $88.27 billion

See all news
Trustpilot
Live Chat